abbreviation
- Vasc. Pharmacol.
Vascular Pharmacology
Journal
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication venue for
- Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2. 146:-. 2022-01-01
- Molecular weight of different angiotensin II polymers directly determines: Density of endothelial membrane AT1 receptors and coronary vasoconstriction. 58:346-355. 2013-01-01
- The coronary endothelium behaves as a functional diffusion barrier for intravascular Angiotensin II. 58:54-63. 2013-01-01
- Two dissimilar AT1 agonists distinctively activate AT1 receptors located on the luminal membrane of coronary endothelium. 51:314-322. 2009-01-01
- Intracoronary Angiotensin II causes inotropic and vascular effects via different paracrine mechanisms. 41:147-158. 2004-01-01
publisher
- Elsevier Inc. Publisher